Research Presented by Fresenius Medical Care North America at Kidney Week 2021 Demonstrates Commitment to Improving Dialysis Care
Retrieved on:
Thursday, November 4, 2021
Research, 2021 Essex County Council election, Nephrology, American Society of Nephrology, PD, Fresenius Medical Care, Patient, ASN, Severe acute respiratory syndrome coronavirus 2, Dialysis, Risk, Intelligence, HD, Kidney, Maintenance, Disease, COVID-19, GI, Peritoneal dialysis, Initiative, Publication, Mortality, Hospital, Association, INSPIRE, Smartphone, Society, Kidney failure, Pharmaceutical industry, Medical device
WALTHAM, Mass., Nov. 4, 2021 /PRNewswire/ -- Fresenius Medical Care North America (FMCNA), the nation's leading provider of kidney care products and services, today announced the presentation of 40 company-affiliated abstracts at the American Society of Nephrology's (ASN) Kidney Week 2021 ,which runs virtually from Nov. 4-7.
Key Points:
- WALTHAM, Mass., Nov. 4, 2021 /PRNewswire/ -- Fresenius Medical Care North America (FMCNA), the nation's leading provider of kidney care products and services, today announced the presentation of 40 company-affiliated abstracts at the American Society of Nephrology's (ASN) Kidney Week 2021 ,which runs virtually from Nov. 4-7.
- "The depth of scientific works presented demonstrates our ongoing commitment across the company to generate new insights that can improve care delivery and patient outcomes," said Dr. Robert Kossmann, Chief Medical Officer for FMCNA.
- Some of the other abstracts being presented by Fresenius Medical Care, and now available online as part of ASN's Kidney Week 2021, include:
Machine Learning-Driven Prediction of Peritoneal Dialysis Technique Failure . - Fresenius Medical Care North America (FMCNA) is the premier healthcare company focused on providing the highest quality care to people with renal and other chronic conditions.